Strong start in Q120 was negatively impacted by the double whammy of postponed elective procedures and lag in capital equipment purchases as the result of the COVID-19 pandemic.
While adoption of robotics and other enabling technologies was gaining significant momentum quarter over quarter through year-end 2019, delays in elective spine surgery due to the COVID-19 pandemic resulted in declines in capital equipment sales and fewer computer-assisted spine surgeries in Q120. However, these declines are expected to be temporary and improve as surgeries rebound through the end of the year and into 2021.
Among the many topics covered in the comprehensive Q120 CAS Spine Market Recap* are:
- Q120 CAS Spine Market Highlights
- Companies Adapt and Advance Despite COVID-19
- Smaller Companies Pursue Strategic Alliances
- Q120 Regulatory Highlights
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
SmartTRAK is the leading source of competitive intelligence used by the top 10 global orthopedic & top 15 wound care companies. If you would like a demo of all SmartTRAK has to offer and how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
